How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? (Q41255229)

28 September 2017

How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? (English)

1 reference

28 September 2017

0 references

Ege Can Serefoglu

1

1 reference

28 September 2017

Serkan Altinova

2

1 reference

28 September 2017

Nevzat Serdar Ugras

3

1 reference

28 September 2017

Egemen Akincioglu

4

1 reference

28 September 2017

Erem Asil

5

1 reference

28 September 2017

M Derya Balbay

6

1 reference

28 September 2017

2 March 2012

1 reference

Canadian Urological Association journal

28 September 2017

1 reference

28 September 2017

7

1 reference

28 September 2017

5-6

1 reference

28 September 2017

E293-8

1 reference

Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Is the diagnostic yield of prostate needle biopsies affected by prostate volume?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

The 20-core prostate biopsy protocol--a new gold standard?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling order

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Prostate cancer screening in the Tyrol, Austria: experience and results

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Making the most out of six systematic sextant biopsies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

A model for the number of cores per prostate biopsy based on patient age and prostate gland volume.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer

14 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

The effect of prostate volume on the yield of needle biopsy.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Observations on the doubling time of prostate cancer.The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3668408

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio

19 August 2018

1 reference

12 December 2020

Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer

1 reference

12 December 2020

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

12 December 2020

Re: The 20-core prostate biopsy protocol--a new gold standard?: V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod and L. Boccon-Gibod. J Urol 2008; 179: 504-507

1 reference

12 December 2020

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology

1 reference

12 December 2020

Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction

1 reference

12 December 2020

Prostate cancer detection with two sets of ten-core compared with two sets of sextant biopsies

1 reference

12 December 2020

Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy

1 reference

12 December 2020

Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate

1 reference

12 December 2020

Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation

1 reference

12 December 2020

Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis

1 reference

12 December 2020

Identifiers

DOI

10.5489/CUAJ.11224

1 reference

28 September 2017

1 reference

28 September 2017

PubMed publication ID

22398204

1 reference